Forte Biosciences, Inc. Common Stock FBRX
$76.83
-0.04%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $69.50
- Implied Upside
- -9.5%
- Price Target Range
- $61.00 – $77.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-28 | BarclaysEtzer Darout |
Downgrades | Overweight → Equal-weight | $74 → $77 |
| 2026-07-21 | BarclaysEtzer Darout |
Initiates coverage on | Overweight | $74 |
| 2025-11-25 | Evercore ISI GroupGavin Clark-Gartner |
Initiates coverage on | Outperform | $65 |
| 2025-11-17 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $61 |
| 2025-08-18 | GuggenheimYatin Suneja |
Initiates coverage on | Buy | $75 |
| 2025-08-15 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $61 |
| 2025-06-24 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $61 |
| 2025-04-01 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $64 → $61 |
| 2025-01-21 | TD CowenYaron Werber |
Initiates coverage on | Buy | — |
| 2024-12-04 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $64 |
| 2024-11-15 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $3 → $64 |
| 2024-08-19 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $75 |
| 2024-05-30 | Brookline CapitalKumaraguru Raja |
Initiates coverage on | Buy | $100 |
| 2024-04-08 | Ladenburg ThalmannMichael Higgins |
Upgrades | Neutral → Buy | $69 |
| 2021-09-20 | Chardan CapitalKeay Nakae |
Upgrades | Sell → Neutral | $100 → $88 |
| 2021-09-03 | Brookline CapitalKumaraguru Raja |
Downgrades | Buy → Hold | — |
| 2021-09-03 | Chardan CapitalKeay Nakae |
Downgrades | Buy → Sell | $100 |
| 2021-09-03 | Ladenburg ThalmannMichael Higgins |
Downgrades | Buy → Neutral | — |
| 2021-09-03 | B. Riley SecuritiesKalpit Patel |
Downgrades | Buy → Neutral | $75 |
| 2021-09-03 | Truist SecuritiesNicole Germino |
Downgrades | Buy → Hold | — |
| 2021-05-14 | B. Riley SecuritiesKalpit Patel |
Initiates coverage on | Buy | $1825 |
| 2021-03-26 | CitigroupMohit Bansal |
Initiates coverage on | Buy | $1875 |
| 2021-03-17 | Chardan CapitalGbola Amusa |
Maintains | Buy | $2875 → $2625 |
| 2020-09-24 | Chardan CapitalGbola Amusa |
Maintains | Buy | $1500 → $2750 |
| 2020-09-10 | Chardan CapitalGbola Amusa |
Maintains | Buy | $1125 → $1500 |
| 2020-08-28 | Brookline CapitalRaja Kumaraguru |
Initiates coverage on | Buy | $2250 |
| 2020-08-28 | Chardan CapitalGbola Amusa |
Upgrades | Neutral → Buy | $1125 |
| 2020-08-25 | Truist SecuritiesNicole Germino |
Initiates coverage on | Buy | $1750 |
| 2020-06-22 | Ladenburg ThalmannMichael Higgins |
Initiates coverage on | Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $76.83
- Market Cap
- $1.63 billion
- 52-Week Range
- $9.10 – $77.20
- Average Volume
- 1.94 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.